Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Aberer, F; Tripolt, NJ; Scharnagl, H; Zedler, J; Eder, M; Oulhaj, A; Stojakovic, T; Sourij, H.
Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitus.
Diab Vasc Dis Res. 2018; 15(2):162-164
Doi: 10.1177/1479164117743939
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Aberer Felix
- Stojakovic Tatjana
- Co-authors Med Uni Graz
- Scharnagl Hubert
- Sourij Harald
- Tripolt Norbert
- Zedler Julian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Patients with type 2 diabetes mellitus face an increased risk of cardiovascular events compared to non-diabetic counterparts. Chronic inflammation and activation of the immune system, including B-lymphocyte maturation is believed to play a role in atherosclerosis. Recent investigations suggest combined serum free light chains as a potential biomarker for cardiovascular events. The aim of this analysis was to investigate the association of combined serum free light chain with carotid atherosclerosis in subjects with type 2 diabetes mellitus. We performed a cross-sectional analysis of data from a prospective single centre 2-year study of 97 patients with type 2 diabetes mellitus and insufficiently controlled cardiovascular risk factors. Complete data on combined serum free light chain, high-sensitivity C-reactive protein were available for 75 subjects. We analysed data of 26 female and 49 male subjects, aged 59 ± 8 years. Their mean body mass index was 31.6 ± 4.4 kg/m2, and the median B-score was 2 (interquartile range: 0-3). Significant positive correlations between combined serum free light chain and the B-score ( r = 0.38; p = 0.001) as well as combined serum free light chain and high-sensitivity C-reactive protein ( r = 0.35; p = 0.002) were observed. The adjusted odds ratio for a half standard deviation increase in combined serum free light chain was 1.48 (95% confidence interval: 1.05-2.05) in an ordinal regression model for carotid B-score. In our study, combined serum free light chain was associated with carotid atherosclerosis in subjects with type 2 diabetes mellitus.
- Find related publications in this database (Keywords)
- Free light chains
- atherosclerosis
- diabetes mellitus
- clinical trial